BPG is committed to discovery and dissemination of knowledge
Articles in Press
11/6/2025 7:49:16 AM | Browse: 5 | Download: 0
Publication Name World Journal of Gastroenterology
Manuscript ID 114377
Country China
Category Gastroenterology & Hepatology
Manuscript Type Randomized Controlled Trial
Article Title Regional multi-center randomized trial of three vonoprazan-amoxicillin dosing regimens for Helicobacter pylori eradication in Sichuan Province, China
Manuscript Source Unsolicited Manuscript
All Author List Chao-Qun Wu, Xiu Zhou, Chang-Ping Li, Qing-Ling He, Zong-Hua Chen, Shun-Bin Ding, Lei Deng, Lin-Lin Chen, Kai Jiang, Cheng-Kui Dong, Lian Hu, Guo-Bing Zhu, Cheng-Gang Zhang, Yan Zhang, Li-Li Wu, Wei Li, Yi-Hong Mao, Hua Zhang, Xia Ai, Yuan-Qing He, Yan Ma and Shuang-Yan He
Funding Agency and Grant Number
Funding Agency Grant Number
Project Fund of the Health Commission of Sichuan Province 19PJ290
Corresponding Author Chang-Ping Li, Professor, Department of Gastroenterology, The Affiliated Hospital of Southwest Medical University, No. 25 Taiping Street, Luzhou 646000, Sichuan Province, China. 506854209@qq.com
Key Words Vonoprazan; Amoxicillin; Helicobacter pylori; Potassium-competitive acid blockers; Dose
Core Tip This multi-center randomized non-inferiority trial compared three vonoprazan (VPZ) plus amoxicillin (AMO) dual-therapy regimens: AMO 0.5 g QID, 0.75 g QID, and 1.0 g TID. All regimens achieved high eradication with excellent compliance and low adverse-event rates. The low-dose, high-frequency option (0.5 g QID) provided efficacy comparable to higher doses with superior tolerability, supporting dose optimization of VPZ-AMO as a practical first-line strategy in high-prevalence regions.
Citation Wu CQ, Zhou X, Li CP, He Ql, Chen ZH, Ding SB, Deng L, Chen LL, Jiang K, Dong CK, Hu L, Zhu GB, Zhang CG, Zhang Y, Wu LL, Li W, Mao YH, Zhang H, Ai X, He YQ, Ma Y, He SY. Regional multi-center randomized trial of three vonoprazan-amoxicillin dosing regimens for Helicobacter pylori eradication in Sichuan Province, China. World J Gastroenterol 2025; In press
Received
2025-09-18 03:42
Peer-Review Started
2025-09-18 05:43
To Make the First Decision
Return for Revision
2025-09-28 10:59
Revised
2025-10-11 11:06
Second Decision
2025-11-06 02:48
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief
2025-11-06 07:49
Articles in Press
2025-11-06 07:49
Publication Fee Transferred
2025-10-18 15:22
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com